Cover Image
市場調查報告書

Sinovac Biotech Ltd. : 產品平台分析

Sinovac Biotech Ltd. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 214148
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Sinovac Biotech Ltd. : 產品平台分析 Sinovac Biotech Ltd. - Product Pipeline Review - 2016
出版日期: 2016年09月30日 內容資訊: 英文 32 Pages
簡介

Sinovac Biotech Ltd 是著重於從事保護人體不受感染疾病危害之疫苗的研究·開發及商品化的生物製藥公司。

本報告提供Sinovac Biotech Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

Sinovac Biotech Ltd.的基本資料

Sinovac Biotech Ltd.概要

  • 主要資訊
  • 企業資料

Sinovac Biotech Ltd.:R&D概要

  • 主要的治療範圍

Sinovac Biotech Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Sinovac Biotech Ltd.:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
    • 第Ⅲ階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第Ⅰ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 被申請了的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Sinovac Biotech Ltd.:藥物簡介

  • entero·病毒 血清型 71 疫苗
  • 肺炎球菌多糖體(23價) 疫苗
  • 小兒麻庳·疫苗
  • 水痘疫苗
  • A型肝炎/B型肝炎 疫苗
  • 流感 A/H7N9形式 疫苗
  • 麻疹/腮腺炎感冒/德國麻疹疫苗
  • 肺炎球菌(13價) 疫苗
  • 克沙奇病毒血清型 A16 疫苗
  • 白喉/破傷風/百日咳 (無細胞) 疫苗
  • 流感菌 血清型 B 疫苗
  • B型肝炎 疫苗
  • 人用狂犬病疫苗
  • 骨髓炎疫苗
  • 輪狀病毒·疫苗
  • 泛出發性流感·疫苗

Sinovac Biotech Ltd.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Sinovac Biotech Ltd.:最近的開發平台趨勢

Sinovac Biotech Ltd.:暫停中的計劃

Sinovac Biotech Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08148CDB

Summary

Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2016', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sinovac Biotech Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Sinovac Biotech Ltd.
  • The report provides overview of Sinovac Biotech Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Sinovac Biotech Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Sinovac Biotech Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Sinovac Biotech Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Sinovac Biotech Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Sinovac Biotech Ltd.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Sinovac Biotech Ltd. Snapshot
    • Sinovac Biotech Ltd. Overview
    • Key Facts
  • Sinovac Biotech Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Sinovac Biotech Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Sinovac Biotech Ltd. - Pipeline Products Glance
    • Sinovac Biotech Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Sinovac Biotech Ltd. - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Sinovac Biotech Ltd. - Drug Profiles
    • (measles + mumps + rubella) vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • chickenpox vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • coxsackievirus [serotype A16] vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • diphtheria + pertussis(acellular) + tetanus vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • haemophilus influenzae B vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • hepatitis A + hepatitis B vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • hepatitis B vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • influenza [strain A/H7N9] vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • polio vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • rabies vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • rotavirus vaccine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Sinovac Biotech Ltd. - Pipeline Analysis
  • Sinovac Biotech Ltd. - Pipeline Products by Molecule Type
  • Sinovac Biotech Ltd. - Dormant Projects
  • Sinovac Biotech Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Sinovac Biotech Ltd., Key Facts
  • Sinovac Biotech Ltd. - Pipeline by Indication, 2016
  • Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016
  • Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016
  • Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016
  • Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016
  • Sinovac Biotech Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
  • Sinovac Biotech Ltd. - Phase I, 2016
  • Sinovac Biotech Ltd. - IND/CTA Filed, 2016
  • Sinovac Biotech Ltd. - Preclinical, 2016
  • Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016
  • Sinovac Biotech Ltd. - Dormant Developmental Projects,2016
  • Sinovac Biotech Ltd., Subsidiaries

List of Figures

  • Sinovac Biotech Ltd. - Pipeline by Top 10 Indication, 2016
  • Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016
  • Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016
  • Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016
  • Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016
  • Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016
Back to Top